C07D 223/32
Containing carbocyclic rings other than six-membered
Official title: containing carbocyclic rings other than six-membered
C07D223/32 (Containing carbocyclic rings other than six-membered) appears on 87 US grants and 63 published applications in this corpus.
Search patents in C07D- Granted patents
- 87
- Published applications
- 63
- Assignees
- 53
- Inventors
- 209
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 3 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 2 |
| 2004 | 1 | 8 |
| 2005 | 0 | 0 |
| 2006 | 4 | 4 |
| 2007 | 3 | 6 |
| 2008 | 2 | 1 |
| 2009 | 0 | 1 |
| 2010 | 4 | 3 |
| 2011 | 1 | 1 |
| 2012 | 2 | 4 |
| 2013 | 4 | 2 |
| 2014 | 1 | 3 |
| 2015 | 4 | 5 |
| 2016 | 5 | 2 |
| 2017 | 3 | 3 |
| 2018 | 3 | 2 |
| 2019 | 3 | 3 |
| 2020 | 1 | 2 |
| 2021 | 0 | 2 |
| 2022 | 1 | 3 |
| 2023 | 1 | 3 |
| 2024 | 1 | 3 |
| 2025 | 4 | 0 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oxidized lappaconitine derivative and use thereof26 May 2026US 12,637,429 B2Qgenetics Co., Ltd.
- Lappaconitine derivative and use thereof6 Jan 2026US 12,516,027 B2Qgenetics Co., Ltd.
- Electroluminescent device2 Dec 2025US 12,486,236 B2Beijing Summer Sprout Technology Co., Ltd.
- Anti-cancer spirocyclic-guanidine compounds and uses thereof9 Sep 2025US 12,410,141 B2The Johns Hopkins University
- Organic electroluminescent compound and organic electroluminescent device comprising the same19 Aug 2025US 12,391,651 B2DuPont Specialty Materials Korea Ltd.
- Potassium channel modulator, composition and application26 Sep 2024US 2024/0317689 A1Neushen Therapeutics (Shanghai) Co., Ltd
- Novel lappaconitine derivative and use thereof14 Mar 2024US 2024/0083850 A1Qgenetics Co., Ltd.
- Novel oxidized lappaconitine derivative and use thereof14 Mar 2024US 2024/0083851 A1Qgenetics Co., Ltd.
- Anti-cancer spirocyclic-guanidine compounds and uses thereof3 Aug 2023US 2023/0242488 A1The Johns Hopkins University
- 5-ht2c receptor agonists and compositions and methods of use23 Feb 2023US 2023/0055376 A1Arena Pharmaceuticals, Inc.
Most cited
By later US patents
- Substituted heterocycle fused gamma-carbolines138US 6,552,017 B1Bristol-Myers Squibb Pharma Company · 2003
- Substituted heterocycle fused gamma-carbolines131US 6,548,493 B1Bristol-Myers Squibb Pharma Company · 2003
- Substituted heterocycle fused gamma-carbolines122US 6,713,471 B1Bristol-Myers Squibb Pharma Company · 2004
- Substituted heterocycle fused gamma-carbolines105US 7,071,186 B2Bristol-Myers Squibb Pharma Company · 2006
- Substituted heterocycle fused γ-carbolines103US 7,183,282 B2Bristol-Myers Squibb Pharma Company · 2007